Puissance Capital Management LP - Q1 2019 holdings

$123 Million is the total value of Puissance Capital Management LP's 6 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q1 2019
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KADMON HLDGS INC10Q3 202016.8%
VIEWRAY INC9Q4 201971.6%
EKSO BIONICS HLDGS INC9Q4 201941.9%
BELLEROPHON THERAPEUTICS INC9Q4 201915.1%
TRACON PHARMACEUTICALS INC8Q4 20199.3%
CORVUS PHARMACEUTICALS INC8Q3 20201.2%
SCYNEXIS INC5Q2 202010.0%
BELLEROPHON THERAPEUTICS INC3Q3 202070.8%
EKSO BIONICS HLDGS INC3Q3 202027.8%
SCYNEXIS INC1Q3 20207.9%

View Puissance Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Puissance Capital Management LP Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ViewRay, Inc.Sold outFebruary 14, 202000.0%

View Puissance Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
42023-10-16
42023-06-07
42023-05-19
42021-06-08
42021-04-26
13F-HR2020-11-12
13F-HR2020-08-14
42020-07-27
42020-05-22
13F-HR2020-05-15

View Puissance Capital Management LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (122956000.0 != 122955000.0)

Export Puissance Capital Management LP's holdings